Aspirin’s Chemopreventive Effects Indicated In Hodgkin’s Lymphoma Study
This article was originally published in The Tan Sheet
Executive Summary
Use of aspirin roughly two times per week over five years may lower the risk for Hodgkin's lymphoma, researchers report in a study exploring an inverse association between the cancer and use of aspirin, other NSAIDS and acetaminophen